Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
[V-kappa’-VH-h-CH2-CH3_V-kappa-VH’]2
Tebotelimab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
scFv-h-CH2-CH3(_scFv)_h-CH2-CH3
Duvortuxizumab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG4-kappa
Odronextamab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
[VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer
Remtolumab
Human
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
VH-VH'-VH
Ozoralizumab
Mouse
ELISA, in vivo assay
Mouse
Monoclonal
IgG2a (LALA, PG), kappa
145-2C11 & MB20-11
Mouse
ELISA, FCM, Functional assay, Research in vivo
Mouse
Monoclonal
IgG2a (D265A), kappa
10F.9G2 & G6-31
Mouse
ELISA, FCM, Functional assay, Research in vivo
Mouse
Monoclonal
IgG2a (D265A), kappa
29F.1A12 &G6-31
Mouse
ELISA, FCM, Functional assay, Research in vivo
Mouse
Monoclonal
IgG2a (D265A), kappa
RMP1-14 & G6-31
Mouse
ELISA, in vivo
Mouse
Monoclonal
IgG2a, kappa
SAA2361